WO2011112970A3 - Compositions and methods for bioconjugation to quantum dots - Google Patents

Compositions and methods for bioconjugation to quantum dots Download PDF

Info

Publication number
WO2011112970A3
WO2011112970A3 PCT/US2011/028154 US2011028154W WO2011112970A3 WO 2011112970 A3 WO2011112970 A3 WO 2011112970A3 US 2011028154 W US2011028154 W US 2011028154W WO 2011112970 A3 WO2011112970 A3 WO 2011112970A3
Authority
WO
WIPO (PCT)
Prior art keywords
quantum dots
methods
bioconjugation
compositions
orthoganl
Prior art date
Application number
PCT/US2011/028154
Other languages
French (fr)
Other versions
WO2011112970A2 (en
Inventor
Hee-Sun Han
Scott A. Hilderbrand
Neal K. Devaraj
Ralph Weissleder
Moungi G. Bawendi
Original Assignee
The General Hospital Corporation
Massachusetts Institute Of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The General Hospital Corporation, Massachusetts Institute Of Technology filed Critical The General Hospital Corporation
Publication of WO2011112970A2 publication Critical patent/WO2011112970A2/en
Publication of WO2011112970A3 publication Critical patent/WO2011112970A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0065—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle
    • A61K49/0067—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the luminescent/fluorescent agent having itself a special physical form, e.g. gold nanoparticle quantum dots, fluorescent nanocrystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056—Peptides, proteins, polyamino acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/334—Polymers modified by chemical after-treatment with organic compounds containing sulfur
    • C08G65/3348—Polymers modified by chemical after-treatment with organic compounds containing sulfur containing nitrogen in addition to sulfur
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L101/00—Compositions of unspecified macromolecular compounds
    • C08L101/02—Compositions of unspecified macromolecular compounds characterised by the presence of specified groups, e.g. terminal or pendant functional groups
    • C08L101/025—Compositions of unspecified macromolecular compounds characterised by the presence of specified groups, e.g. terminal or pendant functional groups containing nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00—Applications
    • C08L2203/02—Applications for biomedical use

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nanotechnology (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

The present disclosure provides for bio-orthoganl and modular conjugation methods for efficient coupling of organic compounds to quantum dots.
PCT/US2011/028154 2010-03-11 2011-03-11 Compositions and methods for bioconjugation to quantum dots WO2011112970A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31278510P 2010-03-11 2010-03-11
US61/312,785 2010-03-11

Publications (2)

Publication Number Publication Date
WO2011112970A2 WO2011112970A2 (en) 2011-09-15
WO2011112970A3 true WO2011112970A3 (en) 2012-01-19

Family

ID=44564151

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/028154 WO2011112970A2 (en) 2010-03-11 2011-03-11 Compositions and methods for bioconjugation to quantum dots

Country Status (1)

Country Link
WO (1) WO2011112970A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3094977T3 (en) 2014-01-14 2018-12-10 European Molecular Biology Laboratory Multiple cycloaddition reactions to select molecules
CN109490523A (en) * 2018-10-22 2019-03-19 北京纳晶生物科技有限公司 Method for the nano material of label, nucleic acid probe and nucleic acid and nano material coupling
WO2020108781A1 (en) * 2018-11-30 2020-06-04 Cnm Technologies Gmbh Immobilisation of receptor molecules on surfaces by tetrazine ligation
CN112098380B (en) * 2020-08-21 2022-06-03 四川大学华西医院 Biological analysis method based on quantum dot selective recognition reaction and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060173362A1 (en) * 2004-10-08 2006-08-03 The Cleveland Clinic Foundation And Vanderbilt University Methods of medical imaging using quantum dots
US20090209508A1 (en) * 2005-05-16 2009-08-20 Universite De Geneve Compounds for Photochemotherapy
US20100025640A1 (en) * 2007-05-02 2010-02-04 Andrij Pich Loading quantum dots into thermo-responsive microgels by reversible transfer from organic solvents to water

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060173362A1 (en) * 2004-10-08 2006-08-03 The Cleveland Clinic Foundation And Vanderbilt University Methods of medical imaging using quantum dots
US20090209508A1 (en) * 2005-05-16 2009-08-20 Universite De Geneve Compounds for Photochemotherapy
US20100025640A1 (en) * 2007-05-02 2010-02-04 Andrij Pich Loading quantum dots into thermo-responsive microgels by reversible transfer from organic solvents to water

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
W J PARAK ET AL.: "Conjugation of DNA to Silanized Colloidal Semiconductor Nanocrystalline Quantum Dots", CHEM. MATER., vol. 14, 2002, pages 2113 - 2119 *

Also Published As

Publication number Publication date
WO2011112970A2 (en) 2011-09-15

Similar Documents

Publication Publication Date Title
WO2012061603A3 (en) Compositions comprising and methods for forming functionalized carbon-based nanostructures
WO2012087962A3 (en) Anti-mesothelin antibodies and immunoconjugates
WO2011153157A3 (en) Benzoquinolone inhibitors of vmat2
IN2012DN06714A (en)
IN2012DN00692A (en)
MX2012001618A (en) 5-fluoropyrimidinone derivatives.
WO2012065019A3 (en) Combination comprising pyridopyrimidinone inhibitors of pi3k alpha
WO2013177062A3 (en) Methods for improving safety of blood-brain barrier transport
WO2011141110A3 (en) Photo-stabilizing agents
MX2012012530A (en) N3-substituted-n1-sulfonyl-5-fluoropyrimidinone derivatives.
WO2013003298A3 (en) Inhibitors of pde10
TW200942530A (en) Pyridine compounds
EP2557919A4 (en) Stabilized statin formulations
WO2010147830A3 (en) Aminothiazole modulators of beta-3-adrenoreceptor
MX2012001620A (en) N1-acyl-5-fluoropyrimidinone derivatives.
WO2011143503A3 (en) Tetracycline compositions
IN2012DN03404A (en)
HRP20170172T1 (en) Compositions pharmaceutiques fortement dosees en biotine
WO2012064743A3 (en) Methods for improving heart function
WO2011112970A3 (en) Compositions and methods for bioconjugation to quantum dots
ZA201207972B (en) Methods for enhancing the palatability of comestible compositions
WO2012054695A8 (en) Antimicrobial amphiphiles and methods for their use
WO2012021678A3 (en) Isolated bacteria, methods for use, and methods for isolation
WO2011146390A3 (en) Compositions and methods for in vivo imaging
WO2011130697A3 (en) Tissue targeting

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11754189

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11754189

Country of ref document: EP

Kind code of ref document: A2